The mechanism of action of SGLT2 inhibitors is independent of insulin action, these drugs have a low risk of hypoglycemia, and reduce body weight, blood pressure, and serum triglyceride level [4, 5]. The gene discussed is SLC5A2; the disease is Hypoglycemia.